233 related articles for article (PubMed ID: 37317866)
1. Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE.
Mahfoud F; Mancia G; Schmieder RE; Ruilope L; Narkiewicz K; Schlaich M; Williams B; Ribichini F; Weil J; Almerri K; Sharif F; Lauder L; Wanten M; Fahy M; Böhm M
Hypertension; 2023 Aug; 80(8):1759-1770. PubMed ID: 37317866
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
Kandzari DE; Townsend RR; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; Konstantinidis D; Choi J; East C; Lauder L; Cohen DL; Kobayashi T; Schmid A; Lee DP; Ma A; Weil J; Agdirlioglu T; Schlaich MP; Shetty S; Devireddy CM; Lea J; Aoki J; Sharp ASP; Anderson R; Fahy M; DeBruin V; Brar S; Böhm M;
J Am Coll Cardiol; 2023 Nov; 82(19):1809-1823. PubMed ID: 37914510
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range.
Mahfoud F; Mancia G; Schmieder RE; Ruilope L; Narkiewicz K; Schlaich M; Williams B; Ribichini F; Weil J; Kao HL; Rodriguez-Leor O; Noory E; Ong TK; Unterseeh T; de Araújo Gonçalves P; Zirlik A; Almerri K; Sharif F; Lauder L; Wanten M; Fahy M; Böhm M
J Am Coll Cardiol; 2022 Nov; 80(20):1871-1880. PubMed ID: 36357087
[TBL] [Abstract][Full Text] [Related]
4. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F
Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557
[TBL] [Abstract][Full Text] [Related]
5. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
Böhm M; Mahfoud F; Ukena C; Hoppe UC; Narkiewicz K; Negoita M; Ruilope L; Schlaich MP; Schmieder RE; Whitbourn R; Williams B; Zeymer U; Zirlik A; Mancia G;
Hypertension; 2015 Apr; 65(4):766-74. PubMed ID: 25691618
[TBL] [Abstract][Full Text] [Related]
6. Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED.
Townsend RR; Ferdinand KC; Kandzari DE; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; David S; Steigerwalt S; Walton A; Hopper I; Bertolet B; Sharif F; Fengler K; Fahy M; Hettrick DA; Brar S; Böhm M
Hypertension; 2024 May; 81(5):1095-1105. PubMed ID: 38314554
[TBL] [Abstract][Full Text] [Related]
7. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.
Pathak A; Rudolph UM; Saxena M; Zeller T; Müller-Ehmsen J; Lipsic E; Schmieder RE; Sievert H; Halbach M; Sharif F; Parise H; Fischell TA; Weber MA; Kandzari DE; Mahfoud F
EuroIntervention; 2023 Sep; 19(7):602-611. PubMed ID: 37427416
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
[TBL] [Abstract][Full Text] [Related]
9. Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years.
Ott C; Mahfoud F; Mancia G; Narkiewicz K; Ruilope LM; Fahy M; Schlaich MP; Böhm M; Schmieder RE
Nephrol Dial Transplant; 2022 Jan; 37(2):304-310. PubMed ID: 34109413
[TBL] [Abstract][Full Text] [Related]
10. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
Mahfoud F; Kandzari DE; Kario K; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Dimitriadis K; Choi JW; East C; D'Souza R; Sharp ASP; Ewen S; Walton A; Hopper I; Brar S; McKenna P; Fahy M; Böhm M
Lancet; 2022 Apr; 399(10333):1401-1410. PubMed ID: 35390320
[TBL] [Abstract][Full Text] [Related]
12. Renal denervation in moderate treatment-resistant hypertension.
Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
[TBL] [Abstract][Full Text] [Related]
13. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
[TBL] [Abstract][Full Text] [Related]
14. 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.
Azizi M; Daemen J; Lobo MD; Mahfoud F; Sharp ASP; Schmieder RE; Wang Y; Saxena M; Lurz P; Sayer J; Bloch MJ; Basile J; Weber MA; Rump LC; Levy T; Sapoval M; Sanghvi K; Rader F; Fisher NDL; Gosse P; Abraham J; Claude L; Barman NC; McClure CK; Liu Y; Kirtane AJ;
JACC Cardiovasc Interv; 2020 Dec; 13(24):2922-2933. PubMed ID: 33357531
[TBL] [Abstract][Full Text] [Related]
15. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
[TBL] [Abstract][Full Text] [Related]
16. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P
Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691
[TBL] [Abstract][Full Text] [Related]
17. Renal Denervation in High-Risk Patients With Hypertension.
Mahfoud F; Mancia G; Schmieder R; Narkiewicz K; Ruilope L; Schlaich M; Whitbourn R; Zirlik A; Zeller T; Stawowy P; Cohen SA; Fahy M; Böhm M
J Am Coll Cardiol; 2020 Jun; 75(23):2879-2888. PubMed ID: 32527396
[TBL] [Abstract][Full Text] [Related]
18. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.
Sesa-Ashton G; Nolde JM; Muente I; Carnagarin R; Lee R; Macefield VG; Dawood T; Sata Y; Lambert EA; Lambert GW; Walton A; Kiuchi MG; Esler MD; Schlaich MP
Hypertension; 2023 Apr; 80(4):811-819. PubMed ID: 36762561
[TBL] [Abstract][Full Text] [Related]
19. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Lobo MD; Sharp ASP; Bloch MJ; Basile J; Wang Y; Saxena M; Lurz P; Rader F; Sayer J; Fisher NDL; Fouassier D; Barman NC; Reeve-Stoffer H; McClure C; Kirtane AJ;
Circulation; 2019 May; 139(22):2542-2553. PubMed ID: 30880441
[TBL] [Abstract][Full Text] [Related]
20. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
